If you are considering filing a Fosamax® lawsuit, you need attorneys with pharmaceutical litigation experience. Contact the Phoenix firm of Phillips and Associates for a free case evaluation.

Phone: e.g. 999-999-9999
  
How Did You Hear About Us?
If You Used A Search Engine, Which One?

Fosamax® Attorneys for Your Lawsuit: Pharmaceutical Litigation Specialists in Phoenix

Some victims of bisphosphonate-induced osteonecrosis of the jaw wish to file a Fosamax® lawsuit to receive compensation for their injuries. Others have contacted Fosamax® attorneys with the hope of causing a recall of the defective prescription drug and holding Merck and Company, Inc. (Merck) responsible for its negligence in failing to warn consumers about the dangers of Fosamax®. Whatever your reason for pursuing pharmaceutical litigation regarding Fosamax®, the attorneys at Phoenix's Phillips and Associates can assist you.

Merck's Response to Fosamax® Warnings

Although the number of ONJ patients connected to Fosamax® is a smaller percentage than other bisphosphonates, it appears that Merck's handling of the situation has made it the primary focus of bisphosphonate pharmaceutical litigation. The history of Fosamax® warnings shows Merck downplaying the prescription drug's side effects. In fact, some Fosamax® lawsuits contend that while other drug companies issued immediate warnings regarding a possible link between bisphosphonates and ONJ, Merck had to be asked by the FDA to update the Fosamax® labeling. It took the pharmaceutical company almost a year to change the warning information. Even then, the warning seemed to be buried on page 13 of a 22-page document that Merck sent to pharmacists.

back to top

Personal vs. Class Action Fosamax® Lawsuits

Fosamax® lawsuits are beginning to be filed against Merck for failing to better issue warnings about the drug. Some of these Fosamax® lawsuits are seeking class action status. The distinction between a class action lawsuit and personal pharmaceutical litigation may be confusing, but our Fosamax® attorneys can help you decipher the differences.

An individual Fosamax® lawsuit would represent your specific case and its outcome would be based on your personal injury by the defective drug. Any verdict or settlement would be awarded to you.

A class action lawsuit, however, is filed on behalf of "the class." This means a group of individuals affected by the defective drug. In a class action Fosamax® lawsuit, attorneys can use the collective experiences of the group to prove fault against Merck. Class action pharmaceutical litigation could produce larger settlements, but they would be disseminated among the entire class.

back to top

Compensation for Fosamax® Injuries

The pharmaceutical litigation specialists at Phoenix's Phillips and Associates are committed to helping you hold Merck and any other parties who downplayed the dangers of Fosamax® responsible for the lack of warnings that may have lead to undue suffering.

Our Fosamax® attorneys help you fight for justice and compensation. Your Fosamax® lawsuit will be well-prepared and will hold strong arguments. Well versed in pharmaceutical litigation, our attorneys will work to help you recover damages for:

For a free case evaluation of your possible Fosamax® lawsuit by attorneys with solid pharmaceutical litigation experience, contact the Phoenix firm of Phillips and Associates. Our Fosamax® attorneys will further discuss the pros and cons of becoming part of a class action lawsuit or filing an individual Fosamax® lawsuit.

back to top